C66.9 coverage policies: Medicare and commercial payers

73 active Medicare policies list C66.9, and 2 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.

Get free alerts for C66.9

Free account. Policy pages stay open to everyone.

Medicare policies listing C66.9

LCD · NOVITAS-JH-L35396

Biomarkers for Oncology

JH · Effective Oct 1, 2015

LCD · NOVITAS-JL-L35396

Biomarkers for Oncology

JL · Effective Oct 1, 2015

LCD · NGS-J6-L33394

Drugs and Biologicals, Coverage of, for Label and Off-Label Uses

J6 · Effective Oct 1, 2015

LCD · NGS-JK-L33394

Drugs and Biologicals, Coverage of, for Label and Off-Label Uses

JK · Effective Oct 1, 2015

LCD · FIRST_COAST-L34912

Genetic Testing for Lynch Syndrome

J9 · Effective Oct 1, 2015

LCD · NGS-J6-L37810

Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms

J6 · Effective Apr 1, 2019

LCD · NGS-JK-L37810

Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms

JK · Effective Apr 1, 2019

LCD · PALMETTO-JJ-L33461

Implantable Infusion Pump

JJ · Effective Oct 1, 2015

LCD · PALMETTO-JM-L33461

Implantable Infusion Pump

JM · Effective Oct 1, 2015

LCD · NORIDIAN-JE-L34215

Lab: Flow Cytometry

Commercial payer policies listing C66.9

2 policies from 1 payer

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Aetna

Aetna policies listing C66.9, with the code’s status in each
Policy	Effective	Status of C66.9
Pharmacogenetic and Pharmacodynamic TestingPayerPolicy · AETNA-CPB-0715	Feb 27, 2024	Covered
Tumor MarkersPayerPolicy · AETNA-CPB-0352	Mar 5, 2024	Covered